Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Cyclodextrins as multifunctional excipients: Influence of inclusion into β-cyclodextrin on physicochemical and biological properties of tebipenem pivoxil.

Paczkowska M, Szymanowska-Powałowska D, Mizera M, Siąkowska D, Błaszczak W, Piotrowska-Kempisty H, Cielecka-Piontek J.

PLoS One. 2019 Jan 25;14(1):e0210694. doi: 10.1371/journal.pone.0210694. eCollection 2019.

2.

Development of the 1,2,4-triazole-based anticonvulsant drug candidates acting on the voltage-gated sodium channels. Insights from in-vivo, in-vitro, and in-silico studies.

Kaproń B, Łuszczki JJ, Płazińska A, Siwek A, Karcz T, Gryboś A, Nowak G, Makuch-Kocka A, Walczak K, Langner E, Szalast K, Marciniak S, Paczkowska M, Cielecka-Piontek J, Ciesla LM, Plech T.

Eur J Pharm Sci. 2019 Mar 1;129:42-57. doi: 10.1016/j.ejps.2018.12.018. Epub 2018 Dec 28.

PMID:
30594731
3.

Enhanced pharmacological efficacy of sumatriptan due to modification of its physicochemical properties by inclusion in selected cyclodextrins.

Paczkowska M, Mizera M, Sałat K, Furgała A, Popik P, Knapik-Kowalczuk J, Krause A, Szymanowska-Powałowska D, Fojud Z, Kozak M, Paluch M, Cielecka-Piontek J.

Sci Rep. 2018 Nov 1;8(1):16184. doi: 10.1038/s41598-018-34554-w.

4.

Global phosphoproteomic analysis identifies SRMS-regulated secondary signaling intermediates.

Goel RK, Meyer M, Paczkowska M, Reimand J, Vizeacoumar F, Vizeacoumar F, Lam TT, Lukong KE.

Proteome Sci. 2018 Aug 18;16:16. doi: 10.1186/s12953-018-0143-7. eCollection 2018.

5.

Effects of inclusion of cetirizine hydrochloride in β-cyclodextrin.

Paczkowska M, Mizera M, Lewandowska K, Kozak M, Miklaszewski A, Cielecka-Piontek J.

J Incl Phenom Macrocycl Chem. 2018;91(3):149-159. doi: 10.1007/s10847-018-0808-y. Epub 2018 May 4.

6.

The Analysis of the Physicochemical Properties of Benzocaine Polymorphs.

Paczkowska M, Wiergowska G, Miklaszewski A, Krause A, Mroczkowka M, Zalewski P, Cielecka-Piontek J.

Molecules. 2018 Jul 16;23(7). pii: E1737. doi: 10.3390/molecules23071737.

7.

Pathogenic Germline Variants in 10,389 Adult Cancers.

Huang KL, Mashl RJ, Wu Y, Ritter DI, Wang J, Oh C, Paczkowska M, Reynolds S, Wyczalkowski MA, Oak N, Scott AD, Krassowski M, Cherniack AD, Houlahan KE, Jayasinghe R, Wang LB, Zhou DC, Liu D, Cao S, Kim YW, Koire A, McMichael JF, Hucthagowder V, Kim TB, Hahn A, Wang C, McLellan MD, Al-Mulla F, Johnson KJ; Cancer Genome Atlas Research Network, Lichtarge O, Boutros PC, Raphael B, Lazar AJ, Zhang W, Wendl MC, Govindan R, Jain S, Wheeler D, Kulkarni S, Dipersio JF, Reimand J, Meric-Bernstam F, Chen K, Shmulevich I, Plon SE, Chen F, Ding L.

Cell. 2018 Apr 5;173(2):355-370.e14. doi: 10.1016/j.cell.2018.03.039.

8.

Phosphoproteomics Analysis Identifies Novel Candidate Substrates of the Nonreceptor Tyrosine Kinase, Src-related Kinase Lacking C-terminal Regulatory Tyrosine and N-terminal Myristoylation Sites (SRMS).

Goel RK, Paczkowska M, Reimand J, Napper S, Lukong KE.

Mol Cell Proteomics. 2018 May;17(5):925-947. doi: 10.1074/mcp.RA118.000643. Epub 2018 Mar 1.

9.

ActiveDriverDB: human disease mutations and genome variation in post-translational modification sites of proteins.

Krassowski M, Paczkowska M, Cullion K, Huang T, Dzneladze I, Ouellette BFF, Yamada JT, Fradet-Turcotte A, Reimand J.

Nucleic Acids Res. 2018 Jan 4;46(D1):D901-D910. doi: 10.1093/nar/gkx973.

10.

Systematic biobanking, novel imaging techniques, and advanced molecular analysis for precise tumor diagnosis and therapy: The Polish MOBIT project.

Niklinski J, Kretowski A, Moniuszko M, Reszec J, Michalska-Falkowska A, Niemira M, Ciborowski M, Charkiewicz R, Jurgilewicz D, Kozlowski M, Ramlau R, Piwkowski C, Kwasniewski M, Kaczmarek M, Ciereszko A, Wasniewski T, Mroz R, Naumnik W, Sierko E, Paczkowska M, Kisluk J, Sulewska A, Cybulski A, Mariak Z, Kedra B, Szamatowicz J, Kurzawa P, Minarowski L, Charkiewicz AE, Mroczko B, Malyszko J, Manegold C, Pilz L, Allgayer H, Abba ML, Juhl H, Koch F; MOBIT Study Group.

Adv Med Sci. 2017 Sep;62(2):405-413. doi: 10.1016/j.advms.2017.05.002. Epub 2017 Jun 21.

PMID:
28646744
11.

Protein-peptide molecular docking with large-scale conformational changes: the p53-MDM2 interaction.

Ciemny MP, Debinski A, Paczkowska M, Kolinski A, Kurcinski M, Kmiecik S.

Sci Rep. 2016 Dec 1;6:37532. doi: 10.1038/srep37532.

12.

STUDIES OF THE CRYSTALLINE FORM OF CEFUROXIME AXETIL: IMPLICATIONS FOR ITS COMPATIBILITY WITH EXCIPIENTS.

Talaczynska A, Mizera M, Szybowicz M, Nowicka AB, Garbacki P, Paczkowska M, Zalewski P, Kozak M, Oszczapowicz I, Jelinska A, Cielecka-Piontek J.

Acta Pol Pharm. 2016 Sep;73(5):1299-1309.

PMID:
29638070
13.

STABILITY OF CEFPIROME SULFATE IN AQUEOUS SOLUTIONS.

Zalewski P, Jelińska A, Paczkowska M, Garbacki P, Talaczyńska A, Stfpniak P, Cielecka-Piontek J.

Acta Pol Pharm. 2016 Jan-Feb;73(1):23-7.

PMID:
27008797
14.

Amorphous Protic Ionic Systems as Promising Active Pharmaceutical Ingredients: The Case of the Sumatriptan Succinate Drug.

Wojnarowska Z, Knapik J, Rams-Baron M, Jedrzejowska A, Paczkowska M, Krause A, Cielecka-Piontek J, Jaworska M, Lodowski P, Paluch M.

Mol Pharm. 2016 Mar 7;13(3):1111-22. doi: 10.1021/acs.molpharmaceut.5b00911. Epub 2016 Feb 16.

PMID:
26836258
15.

β-Cyclodextrin complexation as an effective drug delivery system for meropenem.

Paczkowska M, Mizera M, Szymanowska-Powałowska D, Lewandowska K, Błaszczak W, Gościańska J, Pietrzak R, Cielecka-Piontek J.

Eur J Pharm Biopharm. 2016 Feb;99:24-34. doi: 10.1016/j.ejpb.2015.10.013. Epub 2015 Nov 22.

PMID:
26592156
16.

Stability of cefozopran hydrochloride in aqueous solutions.

Zalewski P, Skibiński R, Paczkowska M, Garbacki P, Talaczyńska A, Cielecka-Piontek J, Jelińska A.

Drug Dev Ind Pharm. 2016;42(4):572-7. doi: 10.3109/03639045.2015.1054834. Epub 2015 Jun 16.

PMID:
26079426
17.

Stability studies of cefoselis sulfate in the solid state.

Zalewski P, Skibiński R, Talaczyńska A, Paczkowska M, Garbacki P, Cielecka-Piontek J.

J Pharm Biomed Anal. 2015 Oct 10;114:222-6. doi: 10.1016/j.jpba.2015.05.033. Epub 2015 Jun 1.

PMID:
26073113
18.

Complex of rutin with β-cyclodextrin as potential delivery system.

Paczkowska M, Mizera M, Piotrowska H, Szymanowska-Powałowska D, Lewandowska K, Goscianska J, Pietrzak R, Bednarski W, Majka Z, Cielecka-Piontek J.

PLoS One. 2015 Mar 30;10(3):e0120858. doi: 10.1371/journal.pone.0120858. eCollection 2015.

19.

The rs340874 PROX1 type 2 diabetes mellitus risk variant is associated with visceral fat accumulation and alterations in postprandial glucose and lipid metabolism.

Kretowski A, Adamska E, Maliszewska K, Wawrusiewicz-Kurylonek N, Citko A, Goscik J, Bauer W, Wilk J, Golonko A, Waszczeniuk M, Lipinska D, Hryniewicka J, Niemira M, Paczkowska M, Ciborowski M, Gorska M.

Genes Nutr. 2015 Mar;10(2):4. doi: 10.1007/s12263-015-0454-6. Epub 2015 Jan 20.

20.

Application of spectroscopic methods for identification (FT-IR, Raman spectroscopy) and determination (UV, EPR) of quercetin-3-O-rutinoside. Experimental and DFT based approach.

Paczkowska M, Lewandowska K, Bednarski W, Mizera M, Podborska A, Krause A, Cielecka-Piontek J.

Spectrochim Acta A Mol Biomol Spectrosc. 2015 Apr 5;140:132-9. doi: 10.1016/j.saa.2014.12.050. Epub 2014 Dec 25.

PMID:
25589394
21.

The Development and Validation of a Stability-Indicating UHPLC-DAD Method for Determination of Perindopril l-Arginine in Bulk Substance and Pharmaceutical Dosage Form.

Paczkowska M, Zalewski P, Garbacki P, Talaczyńska A, Krause A, Cielecka-Piontek J.

Chromatographia. 2014;77(21-22):1497-1501. Epub 2014 Aug 13.

22.

Assay of Diastereoisomers of Cefuroxime Axetil in Amorphous and Crystalline Forms Using UHPLC-DAD.

Garbacki P, Teżyk A, Zalewski P, Jelińska A, Paczkowska M, Talczyńska A, Oszczapowicz I, Cielecka-Piontek J.

Chromatographia. 2014;77(21-22):1489-1495. Epub 2014 Oct 9.

23.
24.

Stability, compatibility and microbiological activity studies of meropenem-clavulanate potassium.

Cielecka-Piontek J, Szymanowska-Powałowska D, Paczkowska M, Łysakowski P, Zalewski P, Garbacki P.

J Antibiot (Tokyo). 2015 Jan;68(1):35-9. doi: 10.1038/ja.2014.92. Epub 2014 Jul 30.

PMID:
25074659
25.

Tebipenem pivoxyl. Derivative spectroscopy study of stability of the first oral carbapenem.

Cielecka-Piontek J, Paczkowska M, Zalewski P, Talaczyńska A, Mizera M.

Spectrochim Acta A Mol Biomol Spectrosc. 2015 Jan 25;135:14-9. doi: 10.1016/j.saa.2014.06.083. Epub 2014 Jun 23.

PMID:
25036644
26.

The chromatographic approach to kinetic studies of tebipenem pivoxil.

Cielecka-Piontek J, Zalewski P, Paczkowska M.

J Chromatogr Sci. 2015 Feb;53(2):325-30. doi: 10.1093/chromsci/bmu063. Epub 2014 Jun 30.

PMID:
24981980
27.

[Meropenem--therapeutic recommendation after twenty years of presence on pharmaceutical market].

Paczkowska M, Garbacki P, Zalewski P, Talaczyńska A, Cielecka-Piontek J.

Postepy Hig Med Dosw (Online). 2014 May 8;68:441-5. doi: 10.5604/17322693.1101541. Review. Polish.

28.

Solid-state stability and compatibility studies of clavulanate potassium.

Cielecka-Piontek J, Paczkowska M, Zalewski P, Lewandowska K, Barszcz B.

Pharm Dev Technol. 2015 Mar;20(2):146-52. doi: 10.3109/10837450.2013.852571. Epub 2013 Nov 13.

PMID:
24219797
29.

Solid-state stability study of meropenem - solutions based on spectrophotometric analysis.

Cielecka-Piontek J, Paczkowska M, Lewandowska K, Barszcz B, Zalewski P, Garbacki P.

Chem Cent J. 2013 Jun 8;7(1):98. doi: 10.1186/1752-153X-7-98.

30.

Stress Degradation Studies of Tebipenem and a Validated Stability-Indicating LC Method.

Cielecka-Piontek J, Zalewski P, Barszcz B, Lewandowska K, Paczkowska M.

Chromatographia. 2013 Apr;76(7-8):381-386. Epub 2012 Oct 5.

31.

The use of UV, FT-IR and Raman spectra for the identification of the newest penem analogs: solutions based on mathematic procedure and the density functional theory.

Cielecka-Piontek J, Lewandowska K, Barszcz B, Paczkowska M.

Spectrochim Acta A Mol Biomol Spectrosc. 2013 Feb 15;103:435-41. doi: 10.1016/j.saa.2012.09.035. Epub 2012 Oct 4.

PMID:
23218399
32.

An application of high performance liquid chromatographic assay for the kinetic analysis of degradation of faropenem.

Cielecka-Piontek J, Krause A, Paczkowska M.

Pharmazie. 2012 Nov;67(11):912-6.

PMID:
23210240
33.

Decaying mouse volatiles perceived by Calliphora vicina Rob.-Desv.

Paczkowski S, Maibaum F, Paczkowska M, Schütz S.

J Forensic Sci. 2012 Nov;57(6):1497-506. doi: 10.1111/j.1556-4029.2012.02245.x. Epub 2012 Sep 12.

PMID:
22970999
34.

[Therapeutic relationship in community psychiatry in the patient and therapist's perspective].

Sosnowska M, Prot-Klinger K, Scattergood M, Paczkowska M, Smolicz A, Ochocka M.

Psychiatr Pol. 2011 Sep-Oct;45(5):723-35. Polish.

PMID:
22220489
35.

[Intrathecal baclofen in severe spasticity due to multiple sclerosis].

Sławek J, Zieliński P, Hołub-Kucharska W, Kaniszewska J, Paczkowska M, Słoniewski P.

Neurol Neurochir Pol. 2003 Sep-Oct;37(5):1135-42; discussion 1143. Polish.

PMID:
15174259
36.

[Tools for a clinical assessment of patients' attitudes toward their schizophrenic illness: 1. "Experience of illness" scale (EIS)].

Wciórka J, Krzyzanowska J, Bacia-Otto M, Muskat K, Dymecka-Kühn A, Matałowski P, Paczkowska M.

Psychiatr Pol. 1996 May-Jun;30(3):381-96. Polish.

PMID:
8848501

Supplemental Content

Loading ...
Support Center